Identity
- Trade Name
- TISSUE WASH SOLUTION C, l L bottle FDA UDI
- Generic Name
- Ex vivo cell culture medium FDA UDI
- Model / Reference
- 04-1068Q FDA UDI
Identifiers
- Catalog Number
- 04-1068Q FDA UDI
- Primary DI / UDI-DI
- 00840075400431 FDA UDI
- FDA Product Code
- KIP FDA UDI
- GMDN Term
- Ex vivo cell culture medium FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 864.2875 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Ex vivo cell culture medium
TISSUE WASH SOLUTION C, l L bottle by Lonza Walkersville, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Ex vivo cell culture medium.
- Expression Systems — EXPRESSION SYSTEMS LLC.
- Physiologic Water 1L bottle — Lonza Verviers · Class I
- GLS CHO Feed Base M - 100g sample — Lonza Verviers · Class I
- Expression Systems — EXPRESSION SYSTEMS LLC.
- Ferric Citrate solution - 400 ml — Lonza Verviers · Class I
- GLS SP7 - 500ml bottle — Lonza Verviers · Class I
- DMEM/F12 Baxter Special 9, 500L — Lonza Verviers · Class I
- Bulk Packaged ster filtered WFI-50LSSB — Lonza Verviers · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Lonza Walkersville, Inc.
Sources (1)
- FDA UDI 3aef344e-e328-40d7-9c3d-f36e67c3e634 33 fields · synced Jun 6, 2026